TARS
NASDAQ · Pharmaceuticals
Tarsus Pharmaceuticals Inc
$63.39
+0.23 (+0.36%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-22.49%
1Y
+56.13%
YTD
-21.52%
Open$63.22
Previous Close$63.16
Day High$64.21
Day Low$63.10
52W High$85.25
52W Low$38.51
Volume—
Avg Volume450.2K
Market Cap2.72B
P/E Ratio—
EPS$-1.13
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$73.37
Below
SMA 200
$59.46
Above
RSI (14)
49.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
15 analysts
Price Target
+28.6% upside
Current
$63.39
$63.39
Target
$81.52
$81.52
$66.63
$81.52 avg
$107.19
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 464.75M | 141.37M | 563.29M |
| Net Income | -68,390,886 | -80,362,652 | 118.73M |
| Profit Margin | -14.7% | -60.0% | 21.1% |
| EBITDA | -72,194,204 | -89,061,843 | 174.10M |
| Free Cash Flow | — | — | 127.20M |
| Rev Growth | +159.5% | +47.5% | +0.6% |
| Debt/Equity | 0.21 | 0.32 | 0.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,102.08 | +0.32% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $231.29 | +1.27% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $115.48 | +1.41% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $25.08 | -0.52% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $54.70 | +1.30% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $75.89 | -3.58% | 12.5 | 33.00B |